Composition for the in vivo production of therapeutic products
US6464998B1 · kind B1 · utility
23Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 1996 |
| Grant date | Oct 15, 2002 |
| Priority date | — |
| Expiry date | Jul 11, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides cell compositions for in vivo implantation, and designed for the sustained and controlled delivery of therapeutic substances.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.